Uterine artery embolisation a good bet for uterine fibroid treatment Clinical study 02 February 2013 Pages: 3 - 3
Patient-directed intervention cost effective for CRC screening Clinical study 02 February 2013 Pages: 4 - 4
Beclometasone/formoterol for asthma cost saving in Spain Clinical study 02 February 2013 Pages: 4 - 4
Physicians should be aware of Internet video-sharing sites, and should be ready to respond to patients who obtain information from these sources, Non-clinical study 02 February 2013 Pages: 5 - 5
Low molecular weight heparin (LMWH) is associated with reduced total direct medical costs in patients with venous thromboembolism Media release 02 February 2013 Pages: 5 - 5
Live varicella zoster virus vaccine of value in older adults Clinical study 02 February 2013 Pages: 6 - 6
Which interventions worth it for preventing diabetes in India? Clinical study 02 February 2013 Pages: 6 - 6
There is differing opinion among physicians with regards to the prescribing of opioid analgesics for persistent non-cancer pain, Clinical study 02 February 2013 Pages: 7 - 7
Drug-eluting stents valued over BMS for late stent thrombosis Clinical study 02 February 2013 Pages: 7 - 7
Value of antiplatelets in the spotlight for secondary prevention Clinical study 02 February 2013 Pages: 8 - 8
Ethinylestradiol/drospirenone: potential for interactions in the US Clinical study 02 February 2013 Pages: 8 - 8
Healthcare costs are predicted to increase vastly in the US within the next 75 years, Comment 02 February 2013 Pages: 10 - 10
The impact of dosing regimen on HRQOL in breast cancer Clinical study 02 February 2013 Pages: 10 - 10
The use of DMARDs is significantly delayed in the treatment of rheumatoid arthritis, Media release 02 February 2013 Pages: 10 - 10
The US HHS* has announced that the government will no longer pay for US immigrants' chemotherapy under Medicaid, News item 02 February 2013 Pages: 11 - 11
The EMEA and the US FDA have created a common application for orphan designation of medicines in the EU and the US. Media release 02 February 2013 Pages: 11 - 11
GlaxoSmithKline's Alli [orlistat] and Lily/Amylin's Byetta [exenatide] are making impacts in the obesity drug market, Media release 02 February 2013 Pages: 11 - 11